Table 1.
Detailed information of studies included and predictive strength of IVs in Mendelian randomization analyses (two-sided α = 0.05).
Exposures/outcomes | Consortium | Ethnicity | Sample sizes | nSNP |
---|---|---|---|---|
Omega-3 fatty acids | UK Biobank | European | 114,999 | 12,321,875 |
Lung cancer | ILCCO | European | 18,313 | 8,893,750 |
ILCCO: International Lung Cancer Consortium; SNP: single-nucleotide polymorphism; nSNP: number of SNPs.